Soyabean as a Neutraceutical a Phytopharmacological: Review
Harsha V. Talele*, Shalini
B. Rathod, Sachin S. Pawar, Amol K. Raut and Arvind R. Umarkar
Shree Sureshdada
Jain Institute of Pharmaceutical Education and Research Jamner
Dist: Jalgaon.[M.S.]
ABSTRACT:
From ancient time, soyabean has been
used as a neutraceuticals because of its nutritional value.Soy
protein is mainly used for cardiovascular diseases, in reducing menopausal
symptoms, weight loss , arthritis, brain function , and exercise performance
enhancement These are also known to prevent osteoporosis. Soyabean
also having a role in reducing the risk of coronary heart disease.It
is also used in benign prostatic hyperplasia.
The word glycine is derived from the
Greek - glykys (sweet) and likely refers to
the Sweetness of the pear- shaped (apios in
Greek) edible tubers. The nutritional effect of soyabean
is due to high content of proteins, isoflavones,
carbohydrates, oil, etc.
This review covers the study of pharmacognosy,
pharmacology, its valuable effects different herbal formulas
to various diseases, soyabean preparations, marketed
formulations along with its major side effects and contraindications
KEYWORDS: Soybean, Genistein, Neutraceutical,
Pharmacognosy, Pharmacology.
INTRODUCTION:
Soyabeans
(Fig-1) are the
fully natured dried
seeds of the
plant Glycine soja and
Glycine max belonging
to family Leguminosae.1 or Fabaceae.It is mainly
used as a neutraceutical.
Botanical Classification 2
Kingdom |
Plantae |
Division |
Magnoliophyta |
Class |
Magnoliopsida |
Order |
Fabales |
Family |
Fabaceae |
Genus |
Glycine |
Species |
G – max |
HISTORY:
Soyabeans originated
in southeast Asia.3 Soy has
been a dietary
staple in Asian countries
for at least 5,000 years, and during
the Chou dynasty
in China (1134-246 B.C.), fermentation techniques were discovered that allowed soy
to be prepared
in more easily
digestible forms. Soy was
intorduced to Europe in the 1700’ s. By the
first century AD, soyabeans were
grown in Japan
and many other
countries. Soyabean seed
from China was
planted by a
colonist in the
British colony of
Georgia in 1765. In 1800’s it was
introduced in United States.3,4
In 1904, the famous American chemist, G. W. Carver
discovered that soybeans are a valuable source of protein and oil. In 1929
Morse spent two years researching soybeans in China, where he gathered more
that 10,000 soybean varieties
Although soybeans are native to southeast
Asia, 55 percent of production is in the United States. The US produced 75
million metric tons of soybeans in 2000 of which more than one-third was
exported. Other leading producers of soybeans are Argentina, Brazil, China and
India. Brazil is expected to become the world's biggest soybean exporter in
2004, displacing the United States from the top seat.4,
PHARMACOGNOSY:
Vernacular name :6
· English : Soybean
· Hindi : Soyabean or bhat
· Marathi : Soybin
· Kannada : Sova bean
· Malayalam : Soyabean
· Assmi : Garomah
· Tamil : Soyapayaru
· Telugu : Soyachikkudu
· Bengali : Garikalai
·
Local : Bhatwara, Rumkurthi.
DESCRIPTION:
A) Macroscopic characters:
Soybean is
a small herbaceous
annual plant with
trifoliate leaves and
oval, pubscent
folioles.7 Although most soy seeds are yellow, soy seeds come
in other various seed coat colors, such as: blue, green, dark brown, purplish
black, or black. Soy seed varies in size, too. The seed coat of a mature soy
seed is extremely hard and water resistant so that germ that is encased within
the soy seed is protected. Damages to the seed coat inhibit the seed from
germinating.8
CHEMICAL CONSTITUENTS:
It is a
rich source of
carbohydrates, fats, vitamins, and
minerals. Soya has high
contents of high
quality proteins.1 On
average, dry soybean contains roughly 40% protein, 35% carbohydrate, 20%
soybean oil, and 5% ash (non-aqueous, metal oxides).9 Soy is also a
source of lecithin
or phospholipid.4 It
also contains isoflavones including genistein, daidzein and glycitein, saponins,
phytosterols.10 It also
contains oil ,as well as stearic, linolic and palmitic acids. They
are also rich
in calcium, iron, potassium
,amino acids etc. Soy
protein usually contain
1-3 mg. Of isoflavones per
gram of soy
protein.11 The principal soluble carbohydrates of mature
soybeans are the disaccharide sucrose (range 2.5–8.2%), the trisaccharide
raffinose (0.1–1.0%) composed of one sucrose molecule
connected to one molecule of galactose, and the tetrasaccharide stachyose (1.4 to
4.1%) composed of one sucrose connected to two molecules of galactose.12
USES:
1) Soybean is mainly used as a nutraceutical.
2) Soya contais isoflavones i.e. Genestein and daidzein. They prevents
the oesteoporosis.
3) They also
have preventive role towards
carcinomas.1
4) Soybeans are
used in preventing
cardiovascular diseases.13
5) Soybeans used
in menopausal problems.10
6) It is also
used orally for cyclic breast pain, preventing hot flashes in breast cancer
survivors, premenstrual syndrome (PMS).13
7) It is used for
lowering LDL Cholesterol and Triglycerides.
8) It is used
in slowing the progression of kidney disease, decreasing urine protein
excretion.
9) It is used
for improving memory.
10) It is used
in type 2 diabetes .
11) They are used for their antioxidant and
anti –thrombotic property.
12) In foods,
soy is used as a milk substitute in infant feeding formulas, and as an
alternative to cow's milk.
13) Soy flour
is used as an ingredient in foods, beverages, and condiments.
14) Syobean is currently
aamajor
source of lecithins which
yields liposomes
,used to
formulate stable emulsions and
finds major uses
in food technology.7
15) Soybean meals ,concentrates and
isolates are used as
meat substtiutes.7
16) Soy protein
is used as
adhesives, asphalts, resins. cleaning
materials.
17) Soy
protein is used
in cosmetics, inks, pleather, paitns , paper
coaings.14
NUTRITIONAL VALUES:-15
Soybeans are very rich in nutritive components. Besides the very
high protein content, soybeans contains a lot of fibre and are rich in calcium, magnesium. The soy protein
has a high biological value and contains all the essential amino acids.
Soybeans are rich in unsaturated fatty acids and low in saturated fatty acids,
which need to be avoided
Nutritional values of soybeans(per
100g):
Water |
8.5 |
g |
Energy |
416 |
kcal |
Energy |
1741 |
kJ |
Protein |
36.5 |
g |
Fat (total lipid) |
19.9 |
g |
Fatty acids, saturated |
2.9 |
g |
Fatty acids, mono-unsaturated |
4.4 |
g |
Fatty acids, poly-unsaturated |
11.3 |
g |
Carbohydrates |
30.2 |
g |
Fiber |
9.3 |
g |
Ash |
4.9 |
G |
Isoflavones |
200 |
Mg |
Calcium, Ca |
277 |
Mg |
Iron, Fe |
15.7 |
Mg |
Magnesium, Mg |
280 |
Mg |
Phosphorus, Mg |
704 |
Mg |
Potassium, K |
1797 |
Mg |
Sodium, Na |
2.0 |
Mg |
Zinc, Zn |
4.9 |
Mg |
Copper, Cu |
1.7 |
Mg |
Manganese, Mn |
2.52 |
Mg |
Selenium, Se |
17.8 |
µg |
Vitamin C (ascorbic acid) |
6.0 |
Mg |
Thiamin (vitamin B1) |
0.874 |
Mg |
Riboflavin (vitamin B2) |
0.87 |
Mg |
Niacin (vitamin B3) |
1.62 |
Mg |
Panthotenic acid (vitamin B5) |
0.79 |
Mg |
Vitamin B6 |
0.38 |
Mg |
Folic acid |
375 |
µg |
Vitamin B12 |
0.0 |
µg |
Vitamin A |
2.0 |
µg |
Vitamin E |
1.95 |
Mg |
Soybeans as Neutraceutical :
A neutraceutical is
a food ,with a
medical-Health benefit; the
prevention ,and treatment
of disease. The term "nutraceutical" was coined from "nutrition"
and "pharmaceutical" in 1989 by Stephen DeFelice,
MD, founder and chairman of the Foundation for Innovation in Medicine (FIM),
Cranford, NJ. 16
1) According to DeFelice, nutraceutical can be defined as, "a food (or part of a
food) that provides medical or health benefits, including the prevention and/or
treatment of a disease."16 However, the term nutraceutical as commonly used in marketing has no
regulatory definition.17
2) Neutraceutical may be defined as –‘any substance that
may belong to a
plant, food or an essential component of food providing
definitive medicinal usefulness and
health promotion as well as physiological benifits,
and ultimately minimise the possible risk of the
prevailing chronic disease significantly’18.
Neutraceuticals are hugely popular among
consumers in the
U.S. and other parts
of the world..American sales
for 2003 were
an estimated $ 31 billlion, and
that figure is
expected to grow
substantially over the
following several years. Neutraceuticals are
one of the
fastest-growing segments of the food industry,
especially among affluent
baby boomers.19
The use of neutraceuticals, as an attempt to accomplish desirable
therapeutic outcomes with reduced side effects, as compared with other
therapeutic agents has met with great monetary success 20,21 The preference for the discovery and production of
nutraceuticals over pharmaceuticals is well seen in
pharmaceutical and biotechnology companies.
Some of the pharmaceutical and biotechnology companies, which
commit major resources to the discovery of nutraceuticals
include Monsanto (St Louis, MO), American Home Products (Madison, NJ), DuPont
(Wilmington, DE), Abbott Laboratories (Abbott Park, IL), Warner-Lambert (Morris
Plains, NJ), Johnson and Johnson (New Brunswick, NJ), Novartis (Basel, Switzerland),
Metabolex (Hayward, CA), Genzyme
Transgenic, PPL Therapeutics, Interneuron (Lexington, KY).
However, with all of the aforementioned positive points, nutraceuticals still need support of an extensive
scientific study to prove "their effects with reduced side effects." 22,23
This can be achieved by the enactment of FIM proposed Nutraceutical Research and Education Act (NREA).24The
NREA includes the creation of a Nutraceutical
Commission (NUCOM) specifically for the review and approval of nutraceuticals and the creation of a nutraceutical
research grants program specifically for clinical research. As per FIM, the key
elements of NREA should include a mechanism to create the exclusive rights to
claims necessary for private investment in research and development, and the
creation of appropriate channels for the review, approval, and regulation of
new products and claims. We believe that in so doing the NREA should keep in
check the cost of nutraceuticals and thereby assure
access for everyone.
Classification of neutraceuticals:
Depending upon various charecteristics,
neutraceuticals can be classified
by several methods.
Their major classes can
be as under
1) Neutraceuticals according to
food source.
2)Neutraceuticals
according to their
mechanism.
3)Neutraceuticals
according to their chemical
nature.
4)Neutraceuticals
according to the
higher contents in specific foods.1
Soybeans as a Neutraceutical:-
1) Soy
protein:-
Soy protein has been used since 1959 as
ingredients for its functional properties in a variety of foods such as salad
dressings, soups, vegetarian foods and meat imitations. Its functional
properties are emulsification and texturizing.
Recently the popularity of soy protein is increasing, mainly because of its health
benefits. It has been proven that soy protein can help to prevent heart
problems and many countries allow health claims for food, which are rich in soy
protein.
In the US a soy protein health claim is allowed under the following conditions:
1. One serving must contain at least 6.25 grams of soy protein.
2. One serving may contain max 3 grams of fat, unless the product
consists of or is derived from whole soy and contains no fat in addition to the
fat inherently present in the whole soy. Of these 3 grams of fat max 1 gram may
be saturated fat, representing max 15% of the total calories.
3. The serving must contain less than 20 milligrams of
cholesterol.
4. The food must be low in sodium: less than 480 milligrams for an
individual food, less than 720 milligrams for a main dish and less than 960
milligrams for a meal product.
2) Soybean oil:
Soybean oil is widely used oil and is commonly called ‘vegetable
oil’. Soybean oil is a very healthy food ingredient despite the bad publicity
regarding fats and oils in general. Soybean oil is very popular because it is
cheap, healthful and has a high smoke point. Soybean oil does not contain much
saturated fat. Like all other oils from vegetable origin, soybean oil contains
no cholesterol. Saturated fat and cholesterol cause heart diseases and mainly
found in products from animal origin such as milk, cheese and meat products.Soybean oil contains natural antioxidants which
remain in the oil even after extraction. These antioxidants help to prevent the
oxidative rancidity.
3) Soy isoflavones:- The 3 major isoflavones found in soybeans are genistin,
daidzin, and glycitin.
Their abundance in soy protein preparations varies widely and depends on the
processing techniques used during production.27,28 These compounds
have both estrogenic and antiestrogenic activity 29,30
and effects that are unrelated to estrogen activity.31 Dehulling, flaking, and defatting
soybeans produces a relatively pure preparation of protein that is low in
isoflavones,32,33 whereas methods used to produce textured soy
protein result in a preparation that retains the isoflavones.34 Isoflavone concentrations range from and2 mg/g protein in
textured soy protein, soy flour, and soy granules to 0.6 to 1.0 mg/g protein in
isolated soy protein. Intakes of 45 g soy flour have resulted in a 20- to 40-fold
increase and a 50- to 100-fold increase in blood and urinary isoflavones, respectively,35
Chemical
structure of Daidzein,Genistein,Glycitin 36
R1 |
R2 |
R3 |
Isoflavone |
H |
H |
OH |
Daidzein |
OH |
H |
OH |
Genistein |
H |
OCH3 |
OH |
Glycitein |
Research in several areas of healthcare has shown that consumption
of isoflavones may play a role in lowering risk for
disease. They can fight disease on several fronts. The following potential
health benefits are attributed to isoflavones:
Ease menopause symptoms - The benefits of soy go beyond reducing long-term cancer risk.
Recent studies have found that soy isoflavones can
reduce menopause symptoms such as hot flushes and increase bone density in
women. Indeed, many menopausal and post-menopausal health problems may result
from a lack of isoflavones in the typical Western
diet. Although study results are not entirely consistent, isoflavones
from soy or red clover may be helpful for symptoms of menopause. A study
carried out by "Health Test" in 2004 investigated the prescription behaviour of 27 doctors for women with menopause symptoms.
It showed that isoflavones were recommended twice
(44%) as often as hormonal treatment (22%). The prescribed supplements were
mainly based on the following plants: soy, black cohosh
and hops.
Reduce heart disease risk - Soy isoflavones also appear to reduce
cardiovascular disease risk via several distinct mechanisms. Isoflavones inhibit the growth of cells that form artery
clogging plaque. These arteries usually form blood clots which can lead to a
heart attack. A review of 38 controlled studies on soy and heart disease
concluded that soy is definitely effective for improving cholesterol profile.
There is some evidence that isoflavones are the
active ingredients in soy responsible for improving cholesterol profile.
Protect against prostate problems - Isoflavones
may be benificial for men's health because they may
protect against enlargement of the male prostate gland. Studies show isoflavones slowed prostate cancer growth and caused
prostate cancer cells to die. Isoflavones act against
cancer cells in a way similar to many common cancer-treating drugs.
Isoflavones improve bone health - Soy Isoflavones
help in the preservation of the bone substance and fight osteoporosis. This is
the reason why people in China and Japan very rarely have osteoporosis, despite
their low consumption of dairy products, whereas in Europe and North America
the contrary happens. Unlike estrogen, which helps prevent the destruction of bone,
evidence suggests that isoflavones may also assist in
creating new bone. Other studies are not entirely consistent, but evidence
suggests that genistein and other soy isoflavones can help prevent osteoporosis.
Reduce cancer risk - Isoflavones seem to be protect agains tumors because they
act against cancer cells in a way similar to many common cancer-treating drugs.
Population-based studies show a strong association between consumption of isoflavones and a reduced risk of breast and endometrial
cancer. Women who ate the most soy products and other foods rich in isoflavones reduced their risk of endometrial cancer by
54%.
Pharmacology
In 1999, the Food and Drug Administration
authorized a health claim for the cholesterol-lowering potential of modest intakes
of soy protein. This has been controversial partly because much of the evidence
was based on a meta-analysis published in 199538that some
nutritionists regarded as inadequate. About half of the quoted studies showed
minor or no cholesterol-lowering effects and three of every four trials
included in the meta-analysis had such wide confidence limits that an
alternative conclusion might have been reached with equal validity. The
meta-analysis certainly predicted the variability in results that would follow.
Nevertheless, there have been sufficient well designed and executed studies to
indicate a likely, although quite modest, effect on plasma lipids that seems to
be confounded by as yet unidentified variables.
Subsequent clinical trials have approached the
problem in several ways. Soy protein containing defined amounts of isoflavones has been compared against another source of
protein, mostly casein or whole milk. In some studies, the soy protein has been
largely depleted of its isoflavone content through
ethanolic extraction. Finally, several trials have focused on purified isoflavones, mostly from red clover. The precise
constituent in soy protein responsible for LDL cholesterol (LDL-C) lowering is
uncertain. The isoflavone content has been a strong
candidate since some trials had shown that isoflavone-depleted
protein was ineffective.39,40 In a
statement on behalf of the American Heart
Association Nutrition Committee, Dr John
Erdman suggested that there might be a synergy between the components of soy protein
since no single constituent appeared capable of lowering LDL-C in isolation.41
The absence of a clear dose-response effect even in
those studies that have shown lowering of LDL-C or of non-HDL cholesterol is of
concern.42-44
The bioavailability of soy isoflavones varies substantially for reasons that are only
partly understood.45 Absorption depends on bowel microbial activity,
conjugation to biologically inactive (or less active) entities occurs rapidly,
the pharmacokinetics of individual isoflavones are
dissimilar, and finally, knowledge about the conversion to potentially active
metabolites is fragmentary.46,47
The exact mechanism by which isoflavones alter bone remodeling is incompletely
understood. In vitro studies suggest that this effect may be due in part to
their estrogenic activity because they act like SERMs. They exert estrogen
agonistic, antagonistic, and agonistic/antagonistic effects, depending on
conditions at the estrogen receptor. Two estrogen receptors have been
identified to date. The β subtype is found in the uterus, ovaries, testes,
hypothalamus, kidney, and bone. The β subtype is found in bone, prostate,
heart, vessels, ovaries, brain, and bladder. Isoflavones
bind to both estrogen receptors but with a greater affinity for β subtypes.48
In addition to estrogen receptors, isoflavones also
bind to androgen receptors, progesterone receptors, oxytocin
receptors, and peroxisome proliferator
activator receptors.
Studies on the mechanism of action of isoflavones show that they act on both osteoblasts
and osteoclasts.49-51 Sugimoto and Yamaguchi49
investigated the effects of daidzein in MC3T3-E1 osteoblastic cells. They found that daidzein
caused significant increases in DNA content, protein content, and alkaline phosphatase activity, suggesting a stimulatory effect on osteoblasts. Osteoclast activity
is regulated by phosphorylation of cell membrane
constituents, involving tyrosine kinases.53 Genistein
is one of the naturally occurring tyrosine kinase
inhibitors.52In a study by Blair et al,50
the effects of genistein on avian osteoclasts were found to be achieved through inhibition of
osteoclastic bone resorption
at concentrations that inhibit tyrosine kinase. They
could not document similar effects with daidzein.
Therefore, they concluded that tyrosine kinase
inhibition is a feature of genistein but not daidzein, and it is possibly one of the mechanisms by which
genistein inhibits bone resorption.
These findings were supported by a separate study in which genistein
but not daidzein decreased the secretion of
hydrochloric acid, a contributor of bone resorption.51 This action of genistein was also
found to occur via Tyrosine kinase inhibition.
Soybean as antioxidant:-
Higher amounts of isoflavones reduced
lipid oxidation to a greater extent than low isoflavone
amounts 54. soy isoflavones
reduce markers of oxidative damage 55-57 and improve total
antioxidant status 57-58. Furthermore, in a study of breast cancer
survivors, consumption of soy isoflavones increased
the antioxidant enzyme superoxide dismutase 59. Overall, these
studies suggest that adding soy to your diet may help to support better
antioxidant status.
Soybean in cardiovascular
diseases:-
Soybean fatty acids may have a protective effect for
cardiovascular diseases , independently of the others components of soybean oil
such as phytosterols, and of the other components of
the bean (proteins, isoflavones). Although the high
PUFA content may lead to an enhanced lipoprotein oxidation effect, which is
cancelled by the high vitamin E content of the soybean oil, and to a lower HDL
cholesterol, the low SFA associated with a high PUFA content of the soybean oil
without trans fatty acid (in non hydrogenated oils) may decrease LDL
cholesterol in a positive way. Therefore, a high ALA diet is able to have an
antithrombotic and antiarrythmic effect which
explains its rapid protective effect, but the poor bioavailability of ALA in
soybean oil leads to further studies to prove its own benefit .60
Soybean
used in
osteoporosis:-
Soy protein
proves to be helpful in osteoporosis prevention. This protein
(due to lesser content of sulphur amino acids) cause
less calcium to leave the organism in urine than the animal proteins. Moreover,
isoflavones in soybeans, transformed in the organism
into so-called vegetable estrogens, protects people threatened by osteoporosis
from the loss of bone mass.
Animal experiments have shown that soy consumption increases bone density and
prevents osteoporosis. These results have been confirmed by clinical studies.
Women eating at least 40g of soy products a day (containing about 90mg of phytoestrogens) experienced an increase in bone density.61
Soybeans Improve Memory:
Foods made from whole, organic soybeans like soymilk. Choline has been proven to positively impact brain
development, memory loss, and lecithin helps in preventing deposits of plaque
in the brain and helps memory recall.62
Soybean in Type-2 Diabetes :-
“The results suggest that a dietary modification as easy to
implement as consuming soy-protein-rich foods may help to prevent diabetic
kidney disease in addition to improving blood-lipid profile,”
CONCLUSION:
There are many claims to the benefits of soybeans and its uses; it is belonging to the
family Fabaceae.
Soybeans provide widest range of physiological effects however results of some
studies conducted to explore the beneficial effects of soybeans were positive
and some were negative. Though there are several common use and benefits, the
most popular frequent use is as a neutraceutical.Soybeans
extract contain genistein, Daidzein and Glycitein as
main constituents that uses in cancer, improving bone health.
References:
1)
Kokate C.K., Gokhale S.B., Purohit A.P. ,2008, “Pharmacognosy”, Forty
first edition , Nirali prakashan, Pune , 16.11.
2)
http://en.wikipedia.org./wiki/soybean
3)
http://www.ncsoy.org/ABOUT-SOYABEANSHistory
of soyabeans.aspx
4)
http://beta.rodpub.com/uploads/soy.pdf
5)
D:\review
soyabean\History of Soybeans.mht
6)
http://www.crirec.com/2011/01/soyabean-
7)
Rangari Vinod D.,2003, “Pharmacognosy and Phytochemistry”, part-II ,First edition, Career publications,Nashik,pp-37.
8)
http://microbewiki.kenyon.edu/index.php/Soybean
9)
D:\review
soyabean\Soybean - MicrobeWiki.mht
10)
D:\review
soyabean\Soybean, Herb Monograph - Flora Health Herb
Encyclopedia.mht
11)
Natural medicines
Comprehensive database 4th print ed.2002.pp.1164-1168
12)
Soybean
- Wikipedia, the free encyclopedia.mht
13)
D:\review
soyabean\SOY Monograph Natural Medicines
Comprehensive Database.mht
14)
Soy
protein - Wikipedia, the free encyclopedia
15)
http://www.soya.be/nutritional-values-of-soybeans.php
16)
Brower
V. Nutraceuticals: poised for a healthy slice of the
healthcare market? Nat Biotechnol.1998;16:728-731.
17)
Zeisel SH.
Regulation of "Nutraceuticals." Science.
1999;285:185-186.
18)
Kar ashutosh, 2007,” Pharmacognosy
and Pharmacobiotechnology”,
Second Edition, New age International Publishers,Delhi,735.
19)
http://www.aboutbioscience.org/pdfs/Nutraceuticals.pdf
20)
Nelson
NJ. Purple carrots, margarine laced with wood pulp? Neutraceuticals move into
the supermarket. J Natl Cancer Inst. 1999;91:755-757.
21)
Whitman
M. Understanding the perceived need for complementary and alternative Neutraceuticals:
lifestyle issues. Clin J Oncol
Nurs. 2001; 5:190-194.
22)
Heyland
DK. In search of the magic nutraceuticals: problems
with current approaches. J Nutr.2001;131(9):2591S-2595S.
23)
Elizabeth
AC. Over-the-counter products: nonprescription medications, Neutraceuticals,
and herbal agents. Clin Obstet
Gynecol. 2002;45(1):89-98.
24)
DeFelice
SL. FIM Rationale and Proposed Guidelines for the Neutraceuticals Research and
Education Act - NREA, November 10, 2002. Foundation for Innovation in Medicine.
Available at: http://www.fimdefelice.org/archives/arc.researchact.html.
25)
http://www.soya.be/soy-protein.php
26)
http://www.soya.be/soybean-oil.php
27)
Anderson RL, Wolf WJ. Compositional changes in trypsin inhibitors, phytic acid, saponins and isoflavones related
to soybean processing. J Nutr. 1995; 125: 581S–588S.
28)
Erdman JW Jr, Badger TM,
Lampe JW, Setchell KD, Messina M. Not all soy
products are created equal: caution needed in interpretation of research
results. J Nutr. 2004; 134: 1229S–1233S.
29) Miksicek RJ. Estrogenic flavonoids: structural requirements for biological
activity. Proc Soc Exp Biol Med. 1995; 208: 44–50.
30) Cassidy A,
Bingham S, Setchell K. Biological effects of isoflavones in young women: importance of the chemical
composition of soyabean products. Br J Nutr. 1995; 74: 587–601.
31) Barnes S. Soy isoflavones: phytoestrogens and
what else? J Nutr. 2004; 134: 1225S–1228S.
32) Dwyer JT, Goldin BR, Saul N, Gualtieri L, Barakat S, Adlercreutz H. Tofu
and soy drinks contain phytoestrogens. J Am Diet Assoc. 1994; 94: 739–743.
33) Lusas EW, Riaz MN. Soy protein products: processing and use. J Nutr. 1995; 125: 573S–580S.
34) Morton MS,
Wilcox G, Wahlqvist ML, Griffiths K. Determination of
lignans and isoflavonoids
in human female plasma following dietary supplementation. J Endocrinol. 1994; 142: 251–259.
35) Karr SC, Lampe
JW, Hutchins AM, Slavin JL. Urinary isoflavonoid excretion in humans is dose dependent at low
to moderate levels of soy-protein consumption. Am J Clin Nutr. 1997; 66: 46–51
36) http://www.medicinalfoodnews.com/vol09/issue2005/isoflavones
37) http://www.isoflavones.info/
38) Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects
of soy protein on serum lipids. N
Engl J Med. 1995; 332: 276–282.
39) Crouse JR,
Morgan T, Terry JG, Ellis J, Vitolins M, Burke GL. A
randomized trial comparing the effect of casein with that of soy protein
containing varying amounts of isoflavones on plasma
concentrations of lipids and lipoproteins. Arch Intern Med. 1999; 159: 2070–2076.
40) Wangen KE, Duncan AM, Xu X, Kurzer MS. Soy isoflavones improve plasma lipids in normocholesterolemic
and mildly hypercholesterolemic postmenopausal women.
Am J Clin
Nutr. 2001; 73: 225–231.
41) Erdman JD. Soy
protein and cardiovascular disease. Circulation. 2000; 102: 2555–2559.
42) Teixeira SR,
Potter SM, Weigel R, Hannum
S, Erdman JW, Hasler CM. Effects of feeding 4 levels
of soy protein for 3 and 6 wk on blood lipids and apolipoproteins
in moderately hypercholesterolemic men. Am J Clin Nutr. 2000; 71: 1077–1084.
43) Baum JA, Teng H, Erdman JW, Weigel RW,
Klein BP, Persky VW, Freels
S, Surya P, Bakhit RM, Ramos E, Potter SM. Long-term
intake of soy protein improves blood lipid profiles and increases mononuclear
cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic,
postmenopausal women. Am J Clin Nutr. 1998; 68: 545–551.
44) Tonstad S, Smerud K, Hoie L. A comparison of
the effects of 2 doses of soy protein or caseien on
serum lipids, serum lipoproteins, and plasma total homocysteine
in hypercholesterolemic subjects. Am J Clin Nutr. 2002; 76: 78–84.
45) Busby MG, Jeffcoat AR, Bloeden LT, Koch MA,
Black T, Dix KJ, Heizer WD, Thomas BF, Hill JM,
Crowell JA, Zeisel SH. Clinical characteristics and
pharmacokinetics of purified soy isoflavones:
single-dose administration to healthy men. Am J Clin Nutr. 2002; 75: 126–136.
46) Kelly GE, Nelson
C, Waring MA, Loannou GE,
Reeder AY. Metabolites of dietary (soy) isoflavones
in human urine. Clin Chim Acta. 1993: 9–22.
47) Setchell KDR. Phytoestrogens: the biochemistry, physiology, and
implications for human health of soy isoflavones. Am J Clin Nutr. 1998; 68 (suppl): 1333S–1346S.
48) Kuiper GGJM, Carlsson
BO, Grandien K, et al. Comparison of the ligand
specificity and transcript tissue distribution of estrogen receptors β and
β. Endocrinology
1997;138:863-870.
49) Sugimoto E.,Yamaguchi
M.Stimulatory effect of daidzein
in osteoblastic M C3T3-E1 cells.Biochem
Pharmacol 2000;59:471-475.Blair HC, Jordan SE,
Peterson
50) Blair HC , Jordan
SE. Variable effects of tyrosine kinase inhibitors on
avian osteoblastic osteoclastic
activity and reduction of bone loss in ovariectomized
rats. J Cell Biochem
1996; 61:629-637.
51) Willaims JP, Jordan SE, Barnes S., Blair HC. Tyrosine
kinase inhibitors effects on avain
osteoclastic acid transport, Am J Clin
Nutr 1998;68:13695-13745.
52) 52)Akiyama T. Ishida
J, Nakagawa S, etal
Genistein
a specific inhibitor of
tyrosine specific protein kinases J Biol Chem 1987;262:5592-5595.
53) Brynin R.,soy and its isoflavones a review
of their effects
on bone density. Altem Med
Rev 2002-7: 317-327.
54)
Wiseman
H, O’Reilly JDO, Adlercreutz H, Mallet AI, Bowey EA, Rowland IR, Sanders TAB. Isoflavone phytoestrogens
consumed in soy decrease F2-isoprostane concentrations and increase resistance
of low-density lipoprotein to oxidation in humans. American Journal of Clinical Nutrition
2000; 72:395-400.
55)
Djuric Z,
Chen G, Doerge DR, Heilbrun
LK, Kucuk O. Effect of soy isoflavone
supplementation on markers of oxidative stress in men and women. Cancer Letters 2001; 172:1-6.
56)
Davis
JN, Kucuk O, Djuric Z, Sarkar FH. Soy isoflavone
supplementation in healthy men prevents NF-kB
activation by TNF-a in blood lymphocytes. Free Radical Biology and Medicine
2001; 30:1293-1302.
57)
Chen
CY, Bakhiet RM, Hart V, Holtzman
G. Isoflavones improve plasma homocysteine status and antioxidant defense system in
healthy young men at rest but do not ameliorate oxidative stress inducedc by 80% VO2pk exercise. Annals of Nutrition and Metabolism 2005;
49:33-41.
58)
Bazzoli
DL, Hill S, DiSilvestro RA. Soy protein
antioxidant actions in active, young adult women. Nutrition Research 2002; 22:807-815.
59)
DiSilvestro
RA, Goodman J, Dy E, LaValle
G. Soy isoflavone supplementation elevates
erythrocyte superoxide dismutase, but not ceruloplasmin
in postmenopausal breast cancer survivors. Breast Cancer Research and Treatment 2005; 89:251-255.
60)
http://www.jle.com/en/revues/agro_biotech/ocl/edocs/00/03/36/A6/article.phtml
61)
http://www.polgrunt.pl/en/index.php?Dz=6andID=9andidd=4
62)
http://www.improvememoryclinic.com/foods-to-improve-memory/
63) http://www.sciencedaily.com/releases/2004/08/040803093614.htmhtt
Received on 10.09.2011
Modified on 21.09.2011
Accepted on 30.09.2011
© A&V Publication all right reserved
Research Journal of Pharmacognosy and Phytochemistry.
4(2): March-April 2012,
112-118